Cascadian Therapeutics Announces Changes to Board of Directors
/
Date13 Mar 2017
SEATTLE, March 13, 2017 (GLOBE NEWSWIRE) — Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that Robert W. Azelby has been appointed to... Read More →
BMC Stock Holdings, Inc. Announces Commencement of Public Offering by Selling Stockholders
/
Date13 Mar 2017
ATLANTA, March 13, 2017 (GLOBE NEWSWIRE) — BMC Stock Holdings, Inc. (NASDAQ:BMCH) (“BMC”) announced today the commencement of a public offering of 5,680,165 shares of... Read More →
Blue Capital Declares Quarterly Dividend on Common Shares and Will Release Its First Quarter 2017 Results on May 1, 2017
/
Date13 Mar 2017
HAMILTON, Bermuda, March 13, 2017 (GLOBE NEWSWIRE) — Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH); (“Blue Capital”) has declared a quarterly dividend of $0.30 per common... Read More →
SCYNEXIS Reports Full Year 2016 Financial Results and Provides Company Update
/
Date13 Mar 2017
JERSEY CITY, N.J., March 13, 2017 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ:SCYX), a drug development company committed to the development and commercialization of novel anti-infectives... Read More →
Alarm.com Announces ObjectVideo Acquisition
/
Date13 Mar 2017
TYSONS, Va., March 13, 2017 (GLOBE NEWSWIRE) — Alarm.com (Nasdaq:ALRM), the leading platform for the connected home and business, today announced the acquisition of substantially... Read More →
CURE Pharmaceutical Announces US Patent Allowances for Its Oral Thin Film Technology For Manufacture and Use in Pet Products
/
Date13 Mar 2017
OXNARD, Calif., March 13, 2017 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “company”), a leading disruptive drug delivery technology company serving the pharmaceutical,... Read More →
Coherus BioSciences Reports Fourth Quarter and Full Year 2016 Corporate Highlights and Financial Results
/
Date13 Mar 2017
REDWOOD CITY, Calif., March 13, 2017 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Nasdaq:CHRS), today reviewed corporate events and reported financial results for the fourth quarter... Read More →
Novartis Kisqali® (ribociclib, LEE011) receives FDA approval as first-line treatment for HR+/HER2- metastatic breast cancer in combination with any aromatase inhibitor
/
Date13 Mar 2017
Media release (PDF).pdf Approved based on a first-line Phase III trial that met its primary endpoint of progression-free survival (PFS) at interim analysis due to... Read More →
Connecticut Water Service, Inc. Reports 2016 Earnings
/
Date13 Mar 2017
CLINTON, CONNECTICUT, March 13, 2017 (GLOBE NEWSWIRE) — Connecticut Water Service, Inc. (NASDAQ GS: CTWS) announced Net Income of $23.4 million, or earnings per basic... Read More →
hemCheck approved for trading on Nasdaq First North – Regulatory
/
Date13 Mar 2017
hemCheck begins trading on Nasdaq First North Press Release.pdf hemCheck approved for trading on Nasdaq First North – Regulatory This Press Release should not be... Read More →